Literature DB >> 1489196

Effects of aggregation and solvent on the toxicity of amphotericin B to human erythrocytes.

P Legrand1, E A Romero, B E Cohen, J Bolard.   

Abstract

In aqueous suspensions of amphotericin B (AmB), a polyene antibiotic and antifungal agent, three forms of AmB coexist: monomers, water-soluble oligomers, and non-water-soluble aggregates. The toxicity of the water-soluble self-associated form of AmB compared with that of the non-water-soluble self-associated form was tested by measuring induction of K+ leakage from human erythrocytes, using different suspensions containing the antibiotic and phosphate-buffered saline. These suspensions were obtained from various stock solutions of the antibiotic in dimethyl formamide or dimethyl sulfoxide. Their circular dichroism spectra around 340 nm, indicative of the degree of AmB self-association, were strongly dependent on the concentration of organic solvent in the suspensions. The nonsoluble self-associated form was separated from the water-soluble form by centrifugation. The nonsoluble form was favored by a high concentration of AmB of the stock solution. The kinetics of AmB-induced K+ leakage from human erythrocytes also appeared to be strongly dependent on the AmB concentration of the stock solution being much weaker with concentrated stock solutions. It was concluded that the only form of AmB toxic to human erythrocytes is the water-soluble self-associated form (in contrast with fungal cells on which the monomeric form is also active). This result may be important in the design of new less toxic AmB derivatives and in the understanding of the mechanism of action of liposomal AmB.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1489196      PMCID: PMC284364          DOI: 10.1128/AAC.36.11.2518

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  26 in total

1.  Characterization and time dependence of amphotericin B: deoxycholate aggregation by quasielastic light scattering.

Authors:  M T Lamy-Freund; S Schreier; R M Peitzsch; W F Reed
Journal:  J Pharm Sci       Date:  1991-03       Impact factor: 3.534

Review 2.  Amphotericin B: delivery systems.

Authors:  J Brajtburg; W G Powderly; G S Kobayashi; G Medoff
Journal:  Antimicrob Agents Chemother       Date:  1990-03       Impact factor: 5.191

3.  Thermodynamics and kinetics of incorporation into a membrane.

Authors:  G Schwarz
Journal:  Biochimie       Date:  1989-01       Impact factor: 4.079

4.  The differential effect of liposomal amphotericin B on human erythrocytes and promastigotes of Leishmania sp.

Authors:  H Ramos; E Romero; B E Cohen
Journal:  Acta Cient Venez       Date:  1988

5.  Temperature-dependent modes for the binding of the polyene antibiotic amphotericin B to human erythrocyte membranes. A circular dichroism study.

Authors:  W Szponarski; J Bolard
Journal:  Biochim Biophys Acta       Date:  1987-02-26

6.  Interactions between a paramagnetic analogue of cholesterol and filipin.

Authors:  L Maurin; F Bancel; P Morin; A Bienvenüe
Journal:  Biochim Biophys Acta       Date:  1988-03-22

7.  Recovery of hepatocytes from attack by the pore former amphotericin B.

Authors:  A Binet; J Bolard
Journal:  Biochem J       Date:  1988-07-15       Impact factor: 3.857

8.  Effect of the state of association of melittin and phospholipids on their reciprocal binding.

Authors:  J C Talbot; J Lalanne; J F Faucon; J Dufourcq
Journal:  Biochim Biophys Acta       Date:  1982-07-14

9.  Binding of Cu(II), Tb(III) and Fe(III) to chicken ovotransferrin. A kinetic study.

Authors:  T Taniguchi; K Ichimura; S Kawashima; T Yamamura; Y Tachi'iri; K Satake; H Kihara
Journal:  Eur Biophys J       Date:  1990       Impact factor: 1.733

10.  Effect of the aggregation state of amphotericin B on its interaction with ergosterol.

Authors:  I Gruda; N Dussault
Journal:  Biochem Cell Biol       Date:  1988-03       Impact factor: 3.626

View more
  47 in total

1.  Lyophilized lecithin based oil-water microemulsions as a new and low toxic delivery system for amphotericin B.

Authors:  M A Moreno; P Frutos; M P Ballesteros
Journal:  Pharm Res       Date:  2001-03       Impact factor: 4.200

2.  Design of Micelle Nanocontainers Based on PDMAEMA-b-PCL-b-PDMAEMA Triblock Copolymers for the Encapsulation of Amphotericin B.

Authors:  Ivonne L Diaz; Claudia Parra; Melva Linarez; Leon D Perez
Journal:  AAPS PharmSciTech       Date:  2015-02-11       Impact factor: 3.246

3.  Synthesis of a highly water-soluble derivative of amphotericin B with attenuated proinflammatory activity.

Authors:  Samusi A Adediran; Timothy P Day; Diptesh Sil; Matthew R Kimbrell; Hemamali J Warshakoon; Subbalakshmi S Malladi; Sunil A David
Journal:  Mol Pharm       Date:  2009 Sep-Oct       Impact factor: 4.939

4.  Accelerated healing of cutaneous leishmaniasis in non-healing BALB/c mice using water soluble amphotericin B-polymethacrylic acid.

Authors:  Karina Corware; Debra Harris; Ian Teo; Matthew Rogers; Kikkeri Naresh; Ingrid Müller; Sunil Shaunak
Journal:  Biomaterials       Date:  2011-07-31       Impact factor: 12.479

5.  Reformulation of Fungizone by PEG-DSPE Micelles: Deaggregation and Detoxification of Amphotericin B.

Authors:  Celeste Alvarez; Dae Hwan Shin; Glen S Kwon
Journal:  Pharm Res       Date:  2016-05-19       Impact factor: 4.200

6.  Treatment of experimental visceral leishmaniasis with amphotericin B in stable albumin microspheres.

Authors:  J A Sánchez-Brunete; M A Dea; S Rama; F Bolás; J M Alunda; R Raposo; M T Méndez; S Torrado-Santiago; J J Torrado
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

7.  In vitro renal toxicity and in vivo therapeutic efficacy in experimental murine cryptococcosis of amphotericin B (Fungizone) associated with Intralipid.

Authors:  V Joly; R Farinotti; L Saint-Julien; M Chéron; C Carbon; P Yeni
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

8.  Treatment of murine candidiasis and cryptococcosis with amphotericin B incorporated into egg lecithin-bile salt mixed micelles.

Authors:  J Brajtburg; S Elberg; S J Travis; G S Kobayashi
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

9.  Amphotericin B incorporated into egg lecithin-bile salt mixed micelles: molecular and cellular aspects relevant to therapeutic efficacy in experimental mycoses.

Authors:  J Brajtburg; S Elberg; G S Kobayashi; J Bolard
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

10.  Toxicity mechanisms of amphotericin B and its neutralization by conjugation with arabinogalactan.

Authors:  Sarah Kagan; Diana Ickowicz; Miriam Shmuel; Yoram Altschuler; Edward Sionov; Miriam Pitusi; Aryeh Weiss; Shimon Farber; Abraham J Domb; Itzhack Polacheck
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.